Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651308-22-000080
Filing Date
2022-06-08
Accepted
2022-06-08 17:43:47
Documents
1
Period of Report
2022-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165472461482334.html 4  
1 FORM 4 wf-form4_165472461482334.xml 4 8770
  Complete submission text file 0001651308-22-000080.txt   10254
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVE, CAMANA BAY, PO BOX 1348 GRAND CAYMAN E9 KY1-1108
Business Address
Wang Lai (Reporting) CIK: 0001852291 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 221004371